PIWIL1 and Miyoshi myopathy: Subsequent CCK-8 assays revealed that PIWIL1 overexpression resulted in the resistance of MM cells to bortezomib, dexamethasone, and doxorubicin, while PIWIL1 downregulation induced re-sensitization of MM cells to chemotherapy (Figures 2C–F).